Zevia PBC (NYSE:ZVIA – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.07) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.07), Zacks reports. Zevia PBC had a negative net margin of 14.02% and a negative return on equity of 38.02%. Zevia PBC updated its Q1 2025 guidance to EPS and its FY 2025 guidance to EPS.
Zevia PBC Stock Performance
Zevia PBC stock traded down $0.93 during midday trading on Wednesday, reaching $2.33. 995,851 shares of the company were exchanged, compared to its average volume of 769,843. Zevia PBC has a 1 year low of $0.62 and a 1 year high of $4.99. The company has a market capitalization of $170.12 million, a price-to-earnings ratio of -6.16 and a beta of 0.65. The firm’s 50-day simple moving average is $3.91 and its 200-day simple moving average is $2.36.
Insider Buying and Selling
In other news, Director Rosemary L. Ripley sold 2,567,006 shares of the business’s stock in a transaction dated Thursday, December 5th. The stock was sold at an average price of $1.90, for a total transaction of $4,877,311.40. Following the completion of the sale, the director now owns 2,719,258 shares in the company, valued at approximately $5,166,590.20. The trade was a 48.56 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Amy Taylor sold 11,479 shares of the stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $4.74, for a total value of $54,410.46. Following the completion of the sale, the chief executive officer now owns 1,002,773 shares of the company’s stock, valued at approximately $4,753,144.02. This represents a 1.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 2,582,464 shares of company stock worth $4,950,344. 12.55% of the stock is owned by insiders.
Institutional Investors Weigh In On Zevia PBC
Analyst Ratings Changes
Several equities research analysts have recently commented on ZVIA shares. The Goldman Sachs Group upped their price target on Zevia PBC from $1.15 to $3.75 and gave the stock a “neutral” rating in a research note on Tuesday, January 14th. Telsey Advisory Group restated a “market perform” rating and issued a $4.00 price target on shares of Zevia PBC in a report on Tuesday, January 14th.
Read Our Latest Analysis on ZVIA
About Zevia PBC
Zevia PBC, a beverage company, develops, markets, sells, and distributes various carbonated beverages in the United States and Canada. It offers soda, energy drinks, organic tea, and kidz drinks. The company offers its products through a network of food, drug, warehouse club, mass, natural, convenience, and e-commerce channels, as well as grocery distributors and natural product stores and specialty outlets.
Featured Stories
- Five stocks we like better than Zevia PBC
- How to Calculate Stock Profit
- Super Micro Computer Shares Surge on Compliance News
- The Most Important Warren Buffett Stock for Investors: His Own
- Wall Street’s Most Wanted: 2 Highly Shorted Stocks Right Now
- 3 REITs to Buy and Hold for the Long Term
- Etsy Loses Its Meme Stock Shine – Is It Still a Buy?
Receive News & Ratings for Zevia PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zevia PBC and related companies with MarketBeat.com's FREE daily email newsletter.